Haemonetics HAE Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's common stock, shares, outstanding?
- Haemonetics (HAE) reported common stock, shares, outstanding of $46.83M in Q4 2025.
- How has Haemonetics's common stock, shares, outstanding changed year-over-year?
- Haemonetics's common stock, shares, outstanding decreased by 6.8% year-over-year, from $50.24M to $46.83M.
- What is the long-term trend for Haemonetics's common stock, shares, outstanding?
- Over 4 years (2021 to 2025), Haemonetics's common stock, shares, outstanding has grown at a -1.3% compound annual growth rate (CAGR), from $50.87M to $48.22M.